Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Repurposing drugs for disease modification in multiple sclerosis
Patient centered decision making: Use of conjoint analysis to determine risk-benefit trade-offs for preference sensitive treatment choices.
Cognitive Impairment in Multiple Sclerosis: Clinical Manifestation, Neuroimaging Correlates, and Treatment.
Dimethyl fumarate suppresses Theiler's murine encephalomyelitis virus - induced demyelinating disease by modifying Nrf2-Keap1 pathway.
The effects of teriflunomide on lymphocyte subpopulations in human peripheral blood mononuclear cells in vitro.
EMD Serono Takes on Exclusive Promotion of Rebif® (interferon beta-1a) in the US
A Pilot Trial of Interferon beta-1a in Alzheimer's Disease
Systemic recombinant human interferon-beta treatment of relapsing-remitting multiple sclerosis: pilot study analysis and six-year follow-up.
Treatment of neurological injury with thymosin β4.
CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells.
Channelopathy-related SCN10A gene variants predict cerebellar dysfunction in multiple sclerosis.
Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?
Mitoxantrone: benefits and risks in multiple sclerosis patients.
Testicular hypofunction and multiple sclerosis risk: a record-linkage study.
Berlex continues legal challenge to FDA over MS drug.
Statement on a nonproprietary name adopted by the USAN Council
Epigenetic Modulation of Human Induced Pluripotent Stem Cell Differentiation to Oligodendrocytes.
Getting a Handle on Lymphopenia With Tecfidera
Extensive bilateral lower extremity deep venous thrombosis in a patient on dimethyl fumarate.
Flupirtine
A comparison of phase imaging and quantitative susceptibility mapping in the imaging of multiple sclerosis lesions at ultrahigh field.
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
Clinical experience with repository corticotropin injection in patients with multiple sclerosis experiencing mood changes with intravenous methylprednisolone: a case series.
A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosis.
A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis.

Pages